A Prospective, Multicenter Evaluation of Safety and Diagnostic Outcomes with Robotic-Assisted Bronchoscopy: Results of the Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung (TARGET) Trial

RECOMMENDED

Lung Cancer

The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by Maintenance of Pembrolizumab/ Sacituzumab Govitecan

★ 1 Recommended by Dr Martin Frey, Faculty Member

Clin Lung Cancer

Roisman LC, Mann S, Basel A, Marei R, Krayim B, Kornev G, Asna N, Peled N

doi: 10.1016/j.cllc.2025.02.002

RECOMMENDED

Lung Cancer

Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial

★ 1 Recommended by Dr Martin Frey, Faculty Member

Lung Cancer

Harris RA, Stokes EA, Batchelor TJP, Internullo E, West D, Jordan S, Nicholson AG, Paul I, Jacobs C, Shackcloth M, Feeney S, Anikin V, McGonigle N, Steyn R, Kalkat M, Stavroulias D, Havinden Williams M, Qadri S, Dobbs K, Zamvar V, Macdonald L, Kaur S, Rogers CA, Lim E, VIOLET trialists

doi: 10.1016/j.lungcan.2024.108070

RECOMMENDED

Lung Cancer

Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Int J Radiat Oncol Biol Phys

Rimner A, Dejonckheere CS, Sahlmann J, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Waller CF, Schmid S, Stolz D, Miederer M, Brose A, Binder H, König J, Grosu AL, Nestle U, Gkika E

doi: 10.1016/j.ijrobp.2025.02.041

RECOMMENDED

Lung CancerPleural Diseases

Diagnostic performance of shape-sensing robotic-assisted bronchoscopy for pleural-based and fissure-based pulmonary lesions

★ 2 Recommended by Dr Martin Frey, Faculty Member

Thorax

Fernandez-Bussy S, Yu Lee-Mateus A, Barrios-Ruiz A, Valdes-Camacho S, Lin K, Ibrahim MI, Vaca-Cartagena BF, Funes-Ferrada R, Reisenauer J, Robertson KS, Hazelett BN, Chadha RM, Abia-Trujillo D

doi: 10.1136/thorax-2024-222502

RECOMMENDED

Lung Cancer

Cryobiopsy versus fine-needle aspiration for shape-sensing robotic-assisted sampling of small lung nodules

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Lung Cancer

Abia-Trujillo D, Funes-Ferrada R, Yu Lee-Mateus A, Barrios-Ruiz A, Khoor A, Patel NM, Hazelett BN, Robertson KS, Fernandez-Bussy S

doi: 10.1016/j.lungcan.2024.107967

RECOMMENDED

Further Publications

Basiliximab Induction Immunosuppression and Lung Transplant Outcomes: Propensity Analysis in a Multicenter Cohort

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Heart Lung Transplant

Rim JG, Hellkamp AS, Neely ML, Reynolds JM, Belperio JA, Budev M, Eason L, Frankel CW, Keshavjee S, Kirchner J, Singer LG, Shah PD, Snyder LD, Samuel Weigt S, Palmer SM, Todd JL

doi: 10.1016/j.healun.2024.11.033

Further Publications

Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study

Am J Respir Crit Care Med

Todd JL, Weigt SS, Neely ML, Grau-Sepulveda MV, Mason K, Sever ML, Kesler K, Kirchner J, Frankel CW, Martinu T, Shino MY, Jackson AM, Pavlisko EN, Williams N, Robien MA, Singer LG, Budev M, Tsuang W, Shah PD, Reynolds JM, Snyder LD, Belperio JA, Palmer SM

doi: 10.1164/rccm.202403-0568OC

RECOMMENDED

Lung Cancer

Ultrathin bronchoscopy with radial endobronchial ultrasound and rapid on-site evaluation for the diagnosis of peripheral pulmonary lesions: a multicentre randomized controlled factorial trial

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Vakil E, Fortin M, Gonzalez AV, Samy L, Chee AC, Dumoulin E, Dvorakova M, Hergott CA, Khalil M, Lampron N, MacEachern P, Martel S, Shieh B, Simon M, Soumagne T, Terzic T, Tremblay A

doi: 10.1016/j.chest.2025.05.020

RECOMMENDED

Lung Cancer

Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients

★ 2 Recommended by Dr Martin Frey, Faculty Member

Clin Lung Cancer

Barrichello APC, Elkrief A, Ricciuti B, Ganta T, Marron TU, Wang X, Lotter W, Lindsay J, Santo V, Cortellini A, Sharma B, Felt K, Pfaff K, Lamberti G, Pecci F, Federico AD, Makarem M, Gandhi MM, Nguyen T, Haradon D, Vaz VR, Johnson BE, Debnath N, Wang Y, Kuang AG, Saeed A, Radford M, Lovly CM, Nebhan CA, Pinato DJ, Rodig SJ, Schoenfeld AJ, Awad MM, Alessi JV, Naqash AR

doi: 10.1016/j.cllc.2025.01.014

Related content

The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by Maintenance of Pembrolizumab/ Sacituzumab Govitecan

Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial

Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial

Diagnostic performance of shape-sensing robotic-assisted bronchoscopy for pleural-based and fissure-based pulmonary lesions

Cryobiopsy versus fine-needle aspiration for shape-sensing robotic-assisted sampling of small lung nodules

Basiliximab Induction Immunosuppression and Lung Transplant Outcomes: Propensity Analysis in a Multicenter Cohort

Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study

Ultrathin bronchoscopy with radial endobronchial ultrasound and rapid on-site evaluation for the diagnosis of peripheral pulmonary lesions: a multicentre randomized controlled factorial trial

Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients